Glenmark initiates process of reorganising itself into three different entities

05 Sep 2019 Evaluate

Glenmark Pharmaceuticals has initiated the process of reorganising itself into three different entities and expects the process to be completed in the current fiscal year.

This reorganisation is designed to place Glenmark on an accelerated trajectory and these three different entities will together make up the Glenmark group of companies.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).

Glenmark Pharma Share Price

403.40 -4.00 (-0.98%)
May 23, 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 921.45
Cipla 970.55
Dr. Reddy's Lab 4274.25
Aurobindo Pharma 558.85
Lupin 618.40
View more..